CSIRO, Australia’s national science agency, is aiming to develop new psychedelics to help people with a variety of mental health issues including depression, addiction, end of life anxiety and PTSD.
Under a new license, CSIRO will work with local MedTech companies to improve existing psychedelic products and develop new ones.